The global blood purification equipment market size was valued at USD 17,755.6 million in 2021. It is expected to reach USD 29242.21 million by 2030, growing at a CAGR of 5.7% during the forecast period (2022–2030). Toxic or pathogenic compounds are eliminated from the blood by dialysis, filtration, adsorption procedures, or any combination of these processes. The patient's blood is extracted through blood collection tubing, passed through an external machine or device to clean it out of toxins, endotoxins, or other contaminants, and then returned to the body. The term "blood purification" refers to this procedure. Currently, the technique of purifying blood is frequently used to treat a variety of conditions that are resistant to conventional therapies like surgery and drug administration.
Through various bio-separation techniques like filtration, dialysis, or adsorption, pathogenic agents and toxic substances are removed from the blood during blood purification. Blood purification is favored in many autoimmune and metabolic disorder treatments due to these benefits over traditional methods. Hemodialysis is currently the blood purification method most widely used. The need for sophisticated equipment and devices to purify blood in these hemodialysis patients is fueled by the large patient population suffering from kidney failure.
Get more information on this report Download Sample Report
Increasing Prevalence of Immune and Metabolic Disorders
The burden of immune and metabolic diseases has significantly increased globally over the past ten years. These include autoimmune pancreatitis, rheumatoid arthritis, multiple sclerosis, hepatic disorders, and kidney failure. For instance, according to the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) organization, over 850 million people worldwide had a specific type of kidney disease in 2018. With a projected prevalence of 22.2% among the global spread of kidney diseases, chronic kidney diseases (CKDs) are one of the most prevalent types of kidney disorders. According to the organization, between 5.5 million and 10.5 million people with CKD need dialysis or a transplant. Additionally, patients with CKDs are five to ten times more likely to pass away before developing end-stage kidney disease (ESKDs). As a result, it is anticipated that the alarming rise in patients with immune and metabolic disorders will increase demand for the blood purification technology needed during their treatments, propelling the market's growth.
Increased Technological Developments in Blood Purification Methods
New methods could enhance patient clinical outcomes when combined with technological advancements in blood purification. In managing patients with multiple organ failures, blood purification has traditionally been used as an artificial kidney or liver, and most purifications have been done on an as-needed basis. Medical engineering advancements have made it possible to continuously perform these blood purification procedures, up to 24 hours per day, in critically ill patient populations. Continuous hemodiafiltration is the most beneficial treatment for managing multiple organ failures with the fewest side effects. Additionally, it is anticipated that advancements in using novel biomaterial for vascular access during blood purification treatment will eliminate the health risks associated with the procedure.
Similarly, market participants in the sector primarily focused on producing tools and supplies that address patients' particular disorders. For instance, the product portfolio of Jafron and NxStage primarily targets patients with acute kidney failure. Therefore, it is anticipated that these expanding technological advancements in blood purification tools and methods will positively affect the market's expansion during the forecast period.
High Cost of Machinery
When treating patients in hospitals and clinics, blood purification is a process that involves the use of a blood purification machine, catheter kits, filters, and fluids. It is anticipated that the overall cost of the equipment will go up due to the use of specialized filters for bio-separation techniques like filtration, dialysis, and adsorption in treating various medical conditions. These devices cost more overall because they are well-equipped with cutting-edge features and a touch screen display that makes them user-friendly. Additionally, several products on the market offer various treatment options using a single device, raising the overall cost of producing an item. For instance, the Informed HF440 can perform the following procedures from infants to adults: Slow Continuous Ultrafiltration (SCUF), Continuous Veno-Venous Hemofiltration (CVVH), Continuous Veno-Venous HemoDialysis (CVVHD), Continuous Veno-Venous HemoDiaFiltration (CVVHDF), High Volume Hemofiltration (HVHF), Therapeutic Plasma Exchange (TPE), Cascade Filtration Double Filtration.
Patients' Preferences for Home Hemodialysis (HDD)
Since blood purification tools are crucial to hemodialysis procedures, expanding home hemodialysis use is anticipated to open up new business opportunities for those in the blood purification sector. Patients can self-treat kidney-related disorders with home hemodialysis (HHD). Due to its efficient and patient-centered blood purification method, it serves as a superior alternative to in-center hemodialysis (ICHD). It is anticipated that medical device companies will make sizable investments in home dialysis education in the upcoming decade due to a rise in the use of HHD in numerous nations. For instance, according to the United States Renal Data System, home dialysis use increased by 93.0% in the U.S. from 2007 to 2017. In 2017, 4.0% of all ESRD patients chose HHD, and it's possible to anticipate an increase in the coming years.
The emergence of user-friendly operating systems like the NxStage System One machine for home dialysis and ostensible studies concluding better outcomes of HHD relative to patients undergoing ICHD is credited with this resurgence in HHD. It is anticipated that this change in consumer preferences will present lucrative business opportunities for HHD, supporting the expansion of the market for blood purification devices.
The global blood purification equipment market is segmented by product type, indication, and end-user.
By product type, the global blood purification equipment market is segmented into portable and stationary.
The portable segment contributed the most to the market and is expected to grow at a CAGR of 5.82% during the forecast period. Portable blood purification technology is mobile, adaptable, and practical. These machines have a hand holder or a portable trolley to help move them from one location to another. The segment for portable blood purification equipment is predicted to grow at the highest rate during the study period. This is primarily attributable to the benefits of mobile blood purification equipment, particularly in critical care units, where these advantages include less space utilization and mobility. As a result, these are the most frequently chosen by medical professionals to treat patients, supporting market growth. The market leaders in the sector are also producing this equipment and devices with built-in portable features like trolley wheels, which are further expected to increase the use of these tools in treating patients in emergency care facilities.
Equipment and devices for stationary blood purification are immovable and have transfer restrictions. Several manufacturers, including B. Braun and Informed, previously offered the machine, and it is primarily connected to a circuit inside the critical care unit. It is anticipated that the growth of the stationary blood purification equipment segment will slow down due to the preference shift of healthcare professionals worldwide toward portable devices.
Based on indication, the blood purification equipment market is segmented into sepsis and renal disease segments.
The renal diseases segment contributed the most to the market and is expected to grow at a CAGR of 5.8% during the forecast period. Some kidney-related conditions that may need blood purification through dialysis or kidney transplantation include chronic kidney diseases, end-stage renal diseases, and acute kidney injuries. The market for blood purification equipment is expected to expand due to the rising prevalence of renal diseases globally. For example, according to data from the International Society of Nephrology, the number of people with the end-stage renal disease will rise to 14.5 million by 2030. Renal diseases will grow as a market over the forecast period due to increasing prevalence and mortality rates among patients with the condition and the availability of dialysis techniques specifically tailored to each patient's needs.
Globally, sepsis is an inflammatory condition associated with higher morbidity and mortality rates. The overproduction of cytokines (anti-inflammatory mediators) in the blood causes inflammation. This imbalance between these mediators ultimately results in the possibility of organ failure. Additionally, according to the Centers for Disease Control and Prevention, sepsis affects roughly 1.7 million adult Americans annually. She serves as a significant patient pool for treatment each year.
Based on the end-user, the global blood purification market is segmented into hospitals and clinics and dialysis centers.
The segment of dialysis centers owns the highest market share and is expected to grow at a CAGR of 5.8% over the forecast period. Dialysis facilities are one of the key end users in the blood purification equipment market because most patients in need of blood purification have kidney-related diseases. The market's most significant revenue contributor is anticipated to come from the dialysis center (in-center) segment, where the treatment is administered with the aid of a technician or a nurse. This is explained by the patients' growing preference for these facilities and their accessibility. One benefit of in-center dialysis is that patients do not need any prior medical training because healthcare professionals handle the majority of the tasks, making it more convenient for patients and reducing the chance of treatment errors. However, since most of the time is spent in the clinics during dialysis sessions, treatments at dialysis centers demand a more extended time commitment from patients.
Most patients with sepsis, kidney disease, infectious diseases, and hepatic disorders prefer to receive blood purification treatments at hospitals and clinics with knowledgeable and experienced medical staff. Blood purification equipment market growth for the hospitals and clinics segment is positively impacted by the availability of trained medical staff at hospitals and clinics to provide better services to patients as well as readily available machinery, blood purification equipment, and filter supplies.
Asia-Pacific Dominates the Global Market
The global blood purification equipment market is segmented into North America, Europe, Asia-Pacific, and LAMEA.
Regional Growth Insights Request Sample Pages
The Asia-pacific region is the most significant shareholder of the global blood purification equipment market and is expected to grow at a CAGR of 6.2% during the forecast period. The markets for blood purification in Japan, China, Australia, India, and the rest of Asia-Pacific are studied. Due to its sizable population, numerous chronic and lifestyle diseases, and rapidly increasing prevalence of ESRD, Asia-Pacific presents lucrative opportunities for players in the blood purification equipment market. The growth of the blood purification equipment market in Asia-Pacific is anticipated to be driven by an increase in cases of sepsis, ESRD, CKDs, acute pancreatitis, diabetes, and hypertension as well as a rise in diagnosis rates. The major drivers of the market growth also include the increase in hemodialysis and blood purification procedures in developing nations like China and India.
North America is expected to grow at a CAGR of 5.76%, generating USD 6,163.30 million during the forecast period. Three nations—the United States, Canada, and Mexico—make up the study of North America. Due to the region's well-established healthcare infrastructure, expanding knowledge of blood purifying techniques among healthcare professionals and patients, and increased renal disorders (ESRD and CKD) and sepsis, the market for blood purification equipment is predicted to multiply soon.
Europe is the third largest market contributor to the global market due to a growing patient population (including those with sepsis, ESRD, CKD, and liver failures), high patient disposable income, and stable healthcare infrastructure. Germany, the UK, France, and the rest of Europe are the three nations that make up the analysis of Europe. The demand for blood purification equipment is expected to rise in the region due to an ever-growing patient population with various disorders that may call for blood purification and an increase in European government initiatives.
Due to the region's lower socioeconomic status, limited access to necessary treatments, and shortage of professionals with the required skills and training for blood purification procedures, it is anticipated that the market for blood purification equipment in LAMEA will slowly expand. Brazil, Saudi Arabia, South Africa, and the rest of LAMEA are all included in the analysis. To find untapped opportunities in this region, most market players have concentrated on increasing their foothold in the LAMEA region by implementing strategies like product launches, partnerships and collaboration with hospitals, and the acquisition of dialysis centers.